logo
New York-Based Clara Capital Named to Inc. 5000 List for Second Consecutive Year, Ranking No. 1,240 and Achieving 352% Three-Year Revenue Growth

New York-Based Clara Capital Named to Inc. 5000 List for Second Consecutive Year, Ranking No. 1,240 and Achieving 352% Three-Year Revenue Growth

Business Wire5 hours ago
NEW YORK--(BUSINESS WIRE)-- Clara Capital, a leading provider of customized small business financing solutions, today announced it has been named to the 2025 Inc. 5000 list of the fastest-growing private companies in America, ranking No. 1,240 based on its three-year revenue growth of 352%. This marks the second consecutive year Clara Capital has earned a spot on the prestigious list, which recognizes the nation's most successful independent businesses.
This achievement is a direct reflection of the trust our clients place in us, the dedication of our talented team, and our commitment to delivering tailored financial solutions that help small businesses thrive.
Share
The Inc. 5000 list, published annually by Inc. magazine, celebrates companies that demonstrate exceptional growth, innovation, and resilience. Inclusion places Clara Capital among an elite group of high-performance businesses that are helping to drive the U.S. economy forward.
'Earning a place on the Inc. 5000 for the second year in a row is an incredible honor,' said Ryan Adwar, CEO and Co-Founder of Clara Capital. 'This achievement is a direct reflection of the trust our clients place in us, the dedication of our talented team, and our commitment to delivering tailored financial solutions that help small businesses thrive. We're proud to be recognized among the nation's most dynamic and fast-growing companies, and we're just getting started.'
Since its founding, Clara Capital has specialized in delivering flexible financing solutions—including merchant cash advances, term loans, and lines of credit—to small and medium-sized businesses across all industries. The company's high-touch service model, rapid funding capabilities, and emphasis on long-term client relationships have been central to its success.
In 2024, Clara Capital ranked No. 158 on the Inc. 5000 list and secured a $20 million credit facility to expand its reach, fund a broader range of businesses, and further enhance the customer experience. In 2025, the company surpassed $300 million in total SMB funding, expanded into a new state-of-the-art headquarters, established a strategic treasury relationship with M&T Bank (NYSE: MTB), and continued to strengthen its position as a leader in alternative finance.
ABOUT CLARA CAPITAL
Clara Capital is a New York-based financial services company specializing in customized funding solutions for small and medium-sized businesses nationwide. With a focus on speed, transparency, and partnership, Clara Capital empowers entrepreneurs with the capital they need to grow, adapt, and succeed. For more information, visit www.claracap.com.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ImmunityBio (IBRX) Jumps 14% as on Promising Therapy Candidate Results
ImmunityBio (IBRX) Jumps 14% as on Promising Therapy Candidate Results

Yahoo

timea few seconds ago

  • Yahoo

ImmunityBio (IBRX) Jumps 14% as on Promising Therapy Candidate Results

We recently published . ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best-performing stocks on Wednesday. ImmunityBio soared by 14.17 percent on Wednesday to close at $2.82 apiece as investors cheered promising early findings from its ongoing trial (QUILT-106) to treat a rare blood cancer type with its therapy candidate. In a statement, ImmunityBio, Inc. (NASDAQ:IBRX) said the first phase of QUILT-106 showed highly promising results in the first two patients with Waldenstrom macroglobulinemia (WM)—a type of non-Hodgkins lymphoma (NHL)—using its CD19 CAR-NK (CD19 t-haNK) natural killer cell therapy. The trial aims to evaluate the safety and efficacy of the cell therapy alone, as well as when it is combined with an existing drug called rituximab. According to ImmunityBio, Inc. (NASDAQ:IBRX), both patients tolerated the therapy candidate without any significant side effects. Notably, all infusions were administered in an outpatient setting. Copyright: katrintimoff / 123RF Stock Photo 'One patient achieved a complete response (CR) with CD19 CAR NK monotherapy, while the second patient achieved CR with CD19 CAR-NK in combination with rituximab. Remission was maintained and is ongoing for six months to date,' ImmunityBio, Inc. (NASDAQ:IBRX) said. While we acknowledge the potential of IBRX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Wedbush: Nvidia, AMD China AI Deal a 'Bullish Catalyst' for Big Tech
Wedbush: Nvidia, AMD China AI Deal a 'Bullish Catalyst' for Big Tech

Yahoo

timea few seconds ago

  • Yahoo

Wedbush: Nvidia, AMD China AI Deal a 'Bullish Catalyst' for Big Tech

Aug 14 - Wedbush is calling it a bullish sign for the AI sector. Nvidia (NASDAQ:NVDA) and Advanced Micro Devices (NASDAQ:AMD) are reportedly getting the green light to sell AI chips in China, provided they hand over 15% of profits to the U.S. government. According to sources, Nvidia will share revenue from its H20 AI accelerator, while AMD will do the same with its MI308 chips. Warning! GuruFocus has detected 5 Warning Signs with NVDA. Analyst Daniel Ives said this unusual arrangement removes a key growth barrier for the AI industry, with potential ripple effects for U.S. Big Tech leaders like Microsoft (MSFT), Palantir Technologies (PLTR), Alphabet (NASDAQ:GOOGL), Meta Platforms (NASDAQ:META), and Amazon (NASDAQ:AMZN). Ives noted that keeping the blockade on Nvidia's H20 would have been a gift to Huawei, potentially worth $15 billion annually, and a blow to U.S. competitiveness. He emphasized the U.S. now holds the edge in AI, a first in three decades but warned China's tech giants, including Alibaba (NYSE:BABA), Baidu (BIDU), Tencent (TCEHY), and Xiaomi (XIACF), are ramping up fast. The Middle East's AI push is another battleground, with Saudi Arabia and the UAE looking to U.S. firms for infrastructure and expertise. Wedbush sees the 15% fee as a small price for massive market access. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Well-heeled shoppers shrug off price hikes for Birkenstocks and Bugaboo strollers for now
Well-heeled shoppers shrug off price hikes for Birkenstocks and Bugaboo strollers for now

Yahoo

timea few seconds ago

  • Yahoo

Well-heeled shoppers shrug off price hikes for Birkenstocks and Bugaboo strollers for now

By Helen Reid LONDON (Reuters) -Well-heeled shoppers around the United States seem - so far at least - willing to soak up price hikes for aspirational products from trendy Birkenstock sandals to Bugaboo prams, despite the impact of trade tariffs and belt-tightening elsewhere. German sandal and clog brand Birkenstock has enjoyed strong consumer demand with little pushback from U.S. retailers since hiking prices at the start of July, its chief executive said on Thursday. As brands raise prices and cut costs to mitigate the impact of higher U.S. tariffs on their imported products, a key question is the extent to which consumers will be put off and buy less, or simply walk away from purchases. Comments from Birkenstock, Bugaboo, Coach, Ralph Lauren and other brands at the premium end of the market suggest that, so far, affluent consumers are shrugging off price hikes. "We saw no pushback or cancellations following the July 1st price increases implemented in response to tariffs," Birkenstock CEO Oliver Reichert told analysts on a call, adding demand for the brand has been "tremendously strong." Bank of America, the largest consumer facing U.S. bank, said this week that middle- and upper-income earners spent more on their credit cards in July than the same month last year. In contrast, spending among the lowest income bracket remained flat, the bank found. Overall U.S. consumer spending may stay strong, Bank of America said, as long as higher-income individuals keep spending. Lower-income earners account for only 15% of all U.S. consumer spending, according to Bank of America. However, Procter & Gamble, maker of Tide detergent, reported signs of spending cutbacks among higher-income consumers, indicating that shoppers may be becoming more selective with their purchases. Bugaboo, a Netherlands-based maker of expensive baby gear, also raised prices on its strollers, high chairs and play pens by $50-$300 in May because of U.S. tariffs. Retailers were open and accepting. "In general we did not see any pushback. They are like us. They understand it is a fluid situation," Chief Commercial Officer for North America, Jeanelle Teves, said. Bugaboo manufactures in China and sells strollers for more than $1,000 at Target, Nordstrom, Bloomingdales and independent mom and pop stores. Coach handbags also remain in strong demand despite a gloomier economic outlook: the brand drew in more than 4.6 million new customers in North America this year, many of whom are Gen Z and millennials, Tapestry CEO Joanne Kuvoiserat said on Thursday. Coach, whose popular Tabby shoulder bags retail for $350, will maintain its operating profit margin despite the pressure of tariffs, Kuvoiserat said. Ralph Lauren, meanwhile, raised its annual revenue forecast as shoppers snapped up items like its $398 Polo Bear sweaters. But consumers' behavior in the coming months remains hard to predict, CEO Patrice Louvet highlighted on a conference call with analysts. "The bigger unknown here today is the price sensitivity and how the consumer reacts to the broader pricing environment. So that's what we're watching very closely as we head into the second half." Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store